Zoetis Inc.

ZTS ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item Jun 2024 Mar 2024 Dec 2023 Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
Revenue $2.36B $2.19B $2.21B $2.15B $2.18B $2.00B $2.04B $2.00B
Cost of Revenue $668.0M $643.0M $728.0M $638.0M $607.0M $588.0M $653.0M $607.0M
Gross Profit $1.69B $1.55B $1.49B $1.51B $1.57B $1.41B $1.39B $1.40B
Gross Margin 71.7% 70.6% 67.1% 70.3% 72.2% 70.6% 68.0% 69.7%
Operating Expenses
Research & Development
SG&A Expense $581.0M $547.0M $565.0M $525.0M $556.0M $505.0M $514.0M $501.0M
Operating Income $839.0M $805.0M $709.0M $776.0M $930.0M $760.0M $654.0M $720.0M
Operating Margin 35.5% 36.8% 32.0% 36.1% 42.7% 38.0% 32.1% 36.0%
Interest Expense $59.0M $58.0M $59.0M $59.0M $58.0M $63.0M $62.0M $53.0M
Pretax Income $780.0M $747.0M $650.0M $717.0M $872.0M $697.0M $592.0M $667.0M
Income Tax Expense $156.0M $148.0M $127.0M $121.0M $202.0M $146.0M $132.0M $139.0M
Net Income $624.0M $599.0M $525.0M $596.0M $671.0M $552.0M $461.0M $529.0M
Net Margin 26.4% 27.4% 23.7% 27.7% 30.8% 27.6% 22.6% 26.4%
EPS (Basic) $1.37 $1.31 $1.15 $1.29 $1.45 $1.19 $0.99 $1.13
EPS (Diluted) $1.37 $1.31 $1.14 $1.29 $1.45 $1.19 $0.98 $1.13
Shares Outstanding (Basic) 455.5M 458.0M 461.2M 460.3M 461.9M 463.5M 468.9M 467.8M
Shares Outstanding (Diluted) 456.0M 458.8M 462.3M 461.4M 462.9M 464.6M 470.4M 469.1M
Dividends Per Share $0.43 $0.43 $0.81 $0.00 $0.38 $0.38 $0.70 $0.00
← Newer Page 2 of 8 Older →